The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use
about
The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The European Medicines Agency ...... dicinal Products for Human Use
@ast
The European Medicines Agency ...... dicinal Products for Human Use
@en
The European Medicines Agency ...... dicinal Products for Human Use
@nl
type
label
The European Medicines Agency ...... dicinal Products for Human Use
@ast
The European Medicines Agency ...... dicinal Products for Human Use
@en
The European Medicines Agency ...... dicinal Products for Human Use
@nl
prefLabel
The European Medicines Agency ...... dicinal Products for Human Use
@ast
The European Medicines Agency ...... dicinal Products for Human Use
@en
The European Medicines Agency ...... dicinal Products for Human Use
@nl
P2093
P2860
P1433
P1476
The European Medicines Agency ...... dicinal Products for Human Use
@en
P2093
F. Pignatti
P2860
P304
P356
10.3324/HAEMATOL.2011.048819
P577
2011-09-01T00:00:00Z